Skip to main content

Table 2 Qualitiy of life score (mean) during intravenous TRD-treatment

From: Prevention of disease progression in a patient with a gastric cancer-re-recurrence. Outcome after intravenous treatment with the novel antineoplastic agent taurolidine. Report of a case

 

Day 1

Day 5

Physical

10.6

10.7

Emotional

4.1

4.0

Social

3.0

3.0

Fatigue

12.2

11.8

Pain

1.0

1.0

Dyspnea

2.1

2.2

Global quality of life

9.0

9.1